Synthetic Biology Market
Global Synthetic Biology Market Size, Share & Trends Analysis Report by Product (Enabling Product, Core Product, and Enabled Product), by Technology (Gene Synthesis & Sequencing, Genome Engineering, Bioinformatics, and Others), and by Application (Medical Application, Industrial Application, Food & Agriculture, and Environmental Applications) Forecast Period (2022-2028)
The global synthetic biology market is anticipated to grow at a significant CAGR of 32.0% during the forecast period. Synthetic biology is an emerging field of science and has a broad range of applications in sectors, such as chemical environmental, agriculture, medical, energy, and nanotechnology and is increasingly being adopted in these fields. The increasing adoption of synthetic biology in various industries is expected to fuel the growth of the global synthetic biology industry. Furthermore, technological advancements in the life science sector have resulted in increased speed and reduced cost of DNA amalgamation. This enables researchers to design and integrate adjusted bacterial chromosomes that can be utilized as a part of the generation of cutting-edge biofuels, bio-items, sustainable chemicals, and others. The advancements in modern engineering have enabled scientists to build new sequences of DNA.
Impact of COVID-19 Pandemic on Global Synthetic Biology Market
Covid-19 pandemic had a positive impact on the synthetic biology market attributed to increased demand for innovation and development of vaccines, therapeutics, and diagnostics. Investments made by the governments and various biotechnology and pharmaceutical companies in the science and technology space for the discovery of drugs and synthetic biological products, especially for the development of successful vaccinations to COVID-19 contributed majorly in the growth of synthetic biology market. For instance, in 2020, GenScript Biotech Corporation entered into an exclusive partnership with IP Biotech to distribute a breakthrough test kit designed to measure the levels of neutralizing antibodies in recovered COVID-19 patients. Furthermore, a report from the European Parliamentary Research Service believes that in the view of Covid-19 pandemic, synthetic biology has been viewed as the next step in the advancement in vaccination development as it is being used as a design tool to make vaccines more effective than ever. Owing to the wide application of synthetic biology in the vaccine and drug development against COVID-19, the synthetic biology market is expected to be a major driver during the pandemic era.
Segmental Outlook
The global synthetic biology market is segmented on the basis of product, technology, and applications. Based on the product, the market is segmented into enabling product, core product, and enabled product. Based on technology, the market is segmented into gene synthesis & sequencing, genome engineering, bioinformatics, and others. Based on application, the market is segmented into medical application, industrial application, food & agriculture, and environmental applications. The above-mentioned segments can be customized as per the requirements. Core product includes synthetic genes, synthetic cells, synthetic DNA, chassis organisms and xeno nucleic acid (XNA), and are expected to hold a significant share in the market owing to extensive use of core products in R&D.
Global Synthetic Biology Market Share by Technology, 2021 (%)
Genome Engineering is anticipated to Hold Prominent Share in the Global Synthetic Biology Market
Genome engineering is one of the most prominent technologies used in the field of synthetic biology. Factors, such as the need for rapid, cheap, multiplex modification of genomes, increasing advancements in CRISPR-toolbox and DNA synthesis technologies, and increasing research activities in synthetic biology industry are expected to drive the segmental growth of the market during the forecast period.
Regional Outlooks
The global Synthetic Biologymarket is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The market can be analyzed for particular region or country level as per the requirement. Among these, North America is expected to be the dominating region in the global synthetic biology market due to increasing number of government research programs. However, Asia-Pacific is expected to achieve high growth rate during the forecast period. Major economies contributing to the Asia-Pacific market include China, Japan, and India.
Global Synthetic Biology Market Growth, by Region 2022-2028
The North American Region is Expected to Hold Prominent Share in the Global Synthetic BiologyMarket
North America is expected to hold a prominent share in the global synthetic biology market. The market growth is attributed to the increasing demand for bio-based products, rising R&D funding for synthetic biology, and increased investments by synthetic biology companies. For instance, in 2021, GenScript expanded its gene synthesis manufacturing capabilities in US. The 50,000 sq. ft. facility is located close to GenScript’s headquarters in Piscataway, NJ, houses with fully automated oligo synthesis and sequencing platforms. For customers in US, this facility provides a improved ability to handle large gene synthesis projects, with an expanded capacity to synthesize 4,000-5,000 genes per month. Further, the growing support from the government, private institutions, and increasing R&D investments in the development of the drugs are other major factors that are expected to drive the market growth during the forecast period.
Market Players Outlook
The major companies serving the global synthetic biology market include Twist Bioscience Corp., Merck KGaA, GenScript Biotech Corp., Thermo Fisher Scientific Inc., Amyris Inc., Codexis Inc, Ginkgo Bioworks, and many others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers andacquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in 2022, Intellia Therapeutics, Inc., and Kyverna Therapeutics, a cell therapy company engineering a new class of therapies for autoimmune and inflammatory diseases, announced a licensing and collaboration agreement for the development of an allogeneic CD19 chimeric antigen receptor (CAR) T-cell therapy for the treatment of a variety of B cell-mediated autoimmune diseases.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global synthetic biology market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Synthetic BiologyMarket
• Recovery Scenario of Global Synthetic BiologyMarket
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Amyris Clean Beauty, Inc.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. GenScript Biotech Corp.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Merck KGaA
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Thermo Fisher Scientific Inc.
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Twist Bioscience Corp.
3.6.1. Overview
3.6.2. Financial Analysis
3.6.3. SWOT Analysis
3.6.4. Recent Developments
3.7. Key Strategy Analysis
3.8. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Synthetic Biology Market by Product
4.1.1. Enabling Product
4.1.2. Core Product
4.1.3. Enabled Product
4.2. Global Synthetic Biology Market by Technology
4.2.1. Gene Synthesis & Sequencing
4.2.2. Genome Engineering
4.2.3. Bioinformatics
4.2.4. Others
4.3. Global Synthetic Biology Market by Application
4.3.1. Medical Application
4.3.2. Industrial Application
4.3.3. Food & Agriculture
4.3.4. Environmental Application
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Algenol
6.2. Autolus Therapeutics PLC
6.3. Azenta Life Sciences (Genewiz)
6.4. Butamax Advanced Biofuels LLC
6.5. Codexis Inc.
6.6. DNA TwoPointO Inc. (ATUM)
6.7. Editas Medicine, Inc.
6.8. Flavors & Fragrances Inc. (DuPont)
6.9. Ginkgo Bioworks, Inc.
6.10. Intellia Therapeutics, Inc.
6.11. Integrated DNA Technologies, Inc.
6.12. Kyverna Therapeutics, Inc.
6.13. LGC Ltd.
6.14. OriGene Technologies, Inc.
6.15. Vedanta Biosciences, Inc.
6.16. Viridos, Inc.
1. GLOBAL SYNTHETIC BIOLOGY MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
2. GLOBAL SYNTHETIC BIOLOGY ENABLING PRODUCT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL SYNTHETIC BIOLOGY CORE PRODUCT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL SYNTHETIC BIOLOGY ENABLED PRODUCT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL SYNTHETIC BIOLOGY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
6. GLOBAL SYNTHETIC BIOLOGY BY GENE SYNTHESIS & SEQUENCING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL SYNTHETIC BIOLOGY BY GENOME ENGINEERING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL SYNTHETIC BIOLOGY BY BIOINFORMATICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL SYNTHETIC BIOLOGY BY OTHERTECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL SYNTHETIC BIOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
11. GLOBAL SYNTHETIC BIOLOGY IN MEDICAL APPLICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL SYNTHETIC BIOLOGY IN INDUSTRIAL APPLICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBAL SYNTHETIC BIOLOGY IN FOOD & AGRICULTURE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14. GLOBAL SYNTHETIC BIOLOGY IN ENVIRONMENTAL APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
15. GLOBAL SYNTHETIC BIOLOGY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
16. NORTH AMERICAN SYNTHETIC BIOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
17. NORTH AMERICAN SYNTHETIC BIOLOGY MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
18. NORTH AMERICAN SYNTHETIC BIOLOGY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
19. NORTH AMERICAN SYNTHETIC BIOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
20. EUROPEAN SYNTHETIC BIOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
21. EUROPEAN SYNTHETIC BIOLOGY MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
22. EUROPEAN SYNTHETIC BIOLOGY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
23. EUROPEAN SYNTHETIC BIOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
24. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
25. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
26. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
27. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
28. REST OF THE WORLD SYNTHETIC BIOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
29. REST OF THE WORLD SYNTHETIC BIOLOGY MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
30. REST OF THE WORLD SYNTHETIC BIOLOGY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
31. REST OF THE WORLD SYNTHETIC BIOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL SYNTHETIC BIOLOGY MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL SYNTHETIC BIOLOGY MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL SYNTHETIC BIOLOGY MARKET, 2022-2028 (%)
4. GLOBAL SYNTHETIC BIOLOGY MARKET SHARE BY PRODUCT, 2021 VS 2028 (%)
5. GLOBAL SYNTHETIC BIOLOGY ENABLING PRODUCT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL SYNTHETIC BIOLOGYCORE PRODUCTMARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL SYNTHETIC BIOLOGYENABLED PRODUCTMARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL SYNTHETIC BIOLOGY MARKET SHARE BY TECHNOLOGY, 2021 VS 2028 (%)
9. GLOBAL SYNTHETIC BIOLOGY BY GENE SYNTHESIS & SEQUENCING MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL SYNTHETIC BIOLOGY BY GENOME ENGINEERING MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL SYNTHETIC BIOLOGY BY BIOINFORMATICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL SYNTHETIC BIOLOGY BY OTHER TECHNOLOGY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL SYNTHETIC BIOLOGY MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
14. GLOBAL SYNTHETIC BIOLOGY IN MEDICAL APPLICATION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. GLOBAL SYNTHETIC BIOLOGY IN INDUSTRIAL APPLICATION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16. GLOBAL SYNTHETIC BIOLOGY IN FOOD & AGRICULTURE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
17. GLOBAL SYNTHETIC BIOLOGY IN ENVIRONMENTAL APPLICATIONS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
18. GLOBAL SYNTHETIC BIOLOGY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
19. US SYNTHETIC BIOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
20. CANADA SYNTHETIC BIOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
21. UK SYNTHETIC BIOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
22. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
23. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
24. ITALY SYNTHETIC BIOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
25. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
26. REST OF EUROPE SYNTHETIC BIOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
27. INDIA SYNTHETIC BIOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
28. CHINA SYNTHETIC BIOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
29. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
30. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
31. REST OF ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
32. REST OF THE WORLD SYNTHETIC BIOLOGY MARKET SIZE, 2021-2028 ($ MILLION)
